| View |
|
BRP-013
|
Insulin Glargine
|
Lantus
|
100 I.U./mL (3.64 mg Insulin glargine equivalent to 100 units Human insulin)
|
Solution For Injection (Sc)
|
-
|
|
|
-
|
05 November 2021
|
17 February 2026
|
| View |
|
BRP-013-01
|
Insulin Glargine
|
Podevta
|
100 I.U./mL (3.64 mg Insulin glargine equivalent to 100 units Human insulin)
|
Solution For Injection (Sc)
|
-
|
Sanofi-Aventis Deutschland GmbH
|
Germany
|
-
|
12 May 2021
|
17 February 2026
|
| View |
|
BRP-014
|
Lantus Solostar
|
Insulin Glargine
|
100 Units (equivalent to 3.64 mg)/mL
|
Solution for Injection (SC)
|
-
|
Sanofi-Aventis Deutschland GmbH
|
Germany
|
Renewal
|
17 February 2023
|
26 February 2028
|
| View |
|
BRP-014-01
|
Insulin Glargine
|
Podevta
|
100 Units (equivalent to 3.64 mg)/mL
|
Solution For Injection (SC)
|
-
|
Sanofi-Aventis Deutschland GmbH
|
|
Renewal
|
22 March 2023
|
26 February 2028
|
| View |
|
BRP-017
|
Biphasic Isophane Human Insulin 30/70 (recombinant DNA)
|
Insulet 30/70
|
100 IU/mL
|
Suspension For Injection (Im/Sc)
|
Antidiabetic
|
Aristopharma Ltd.
|
Bangladesh
|
Renewal
|
03 October 2018
|
24 October 2028
|
| View |
|
BRP-018
|
Biphasic Isophane Human Insulin 50/50 (Recombinant DNA)
|
Insulet 50/50
|
100 IU/mL
|
Suspension For Injection (Im/Sc)
|
Antidiabetic
|
Aristopharma Ltd.
|
Bangladesh
|
Renewal
|
13 November 2018
|
24 October 2028
|
| View |
|
BRP-019
|
Regular Insulin Human (Recombinant DNA)
|
Insulet R
|
100 IU/mL
|
Solution For Injection (Im-Iv-Sc)
|
Antidiabetic
|
Aristopharma Ltd.
|
Bangladesh
|
Renewal
|
13 November 2018
|
24 October 2028
|
| View |
|
BRP-020
|
Isophane Insulin Human (Recombinant DNA)
|
Insulet N
|
100 IU/mL
|
Suspension For Injection (Im/Sc)
|
Antidiabetic
|
Aristopharma Ltd.
|
Bangladesh
|
Renewal
|
13 November 2018
|
24 October 2028
|
| View |
|
BRP-021
|
Clostridium Botulinum Toxin Type A
|
Nabota
|
100 Units
|
Lyophilized Powder for Injection (IM/SC)
|
Muscle Relaxant
|
Daewoong Pharmaceutical Co., Ltd.
|
Korea
|
Renewal (Reconstruction)
|
08 March 2024
|
26 January 2025
|
| View |
|
BRP-030
|
Insulin Glulisine
|
Apidra Solostar
|
3.49 mg/mL (equivalent to 100 Units/mL)
|
Solution For Injection (SC)
|
-
|
Sanofi-Aventis Deutschland GmbH
|
Germany
|
-
|
26 February 2021
|
28 October 2025
|
| View |
|
BRP-034
|
Biphasic Isophane Insulin (Rdna Origin)
|
Wosulin-30/70
|
100 IU/mL
|
Suspension For Injection (Sc)
|
Intermediate acting insulin
|
Wockhardt Limited
|
India
|
Renewal
|
21 May 2022
|
05 September 2027
|
| View |
|
BRP-034-01
|
Biphasic Isophane Insulin (Rdna Origin)
|
Glysolin 30/70
|
100 I.U./ mL
|
Suspension For Injection (S.C.)
|
Intermediate acting insulin
|
Wockhardt Ltd.
|
India
|
Automatic Renewal
|
18 July 2022
|
05 September 2027
|
| View |
|
BRP-034-02
|
Biphasic Isophane Insulin (rDNA)
|
Choicesulin
|
100 IU/mL
|
Suspension for Injection (SC)
|
Intermediate Acting Insulin
|
Wockhardt Limited
|
India
|
Renewal
|
05 August 2022
|
05 September 2027
|
| View |
|
BRP-035
|
Regular Insulin Human (Rdna Origin)
|
Wosulin-R
|
100 IU/mL
|
Suspension For Injection (Sc)
|
Short acting insulin
|
Wockhardt Limited
|
India
|
Renewal
|
20 May 2022
|
06 September 2027
|
| View |
|
BRP-035-01
|
Regular Insulin Human (Rdna Origin)
|
Glysolin R
|
100 I.U./ mL
|
Solution For Injection (S.C.)
|
Short acting insulin
|
Wockhardt Ltd.
|
India
|
Automatic Renewal
|
18 July 2022
|
06 September 2027
|
| View |
|
BRP-036
|
Isophane Insulin Human (Rdna Origin)
|
Wosulin-N
|
100 IU/mL
|
Suspension For Injection (Sc)
|
Intermediate acting insulin
|
Wochard Limited
|
India
|
Renewal
|
20 May 2022
|
06 September 2027
|
| View |
|
BRP-036-01
|
Isophane Insulin Human (Rdna Origin)
|
Glysolin N
|
100 I.U./ mL
|
Suspension For Injection (S.C.)
|
Intermediate acting insulin
|
Wockhardt Ltd.
|
India
|
Automatic Renewal
|
18 July 2022
|
06 September 2027
|
| View |
|
BRP-037
|
Insulin Glargine
|
Glaritus
|
100IU/mL
|
Solution for Injection (SC)
|
Long-acting Insulin
|
Wockhardt Ltd.
|
India
|
Renewal
|
28 January 2019
|
03 March 2029
|
| View |
|
BRP-037-01
|
Insulin Glargine
|
Glysolin G
|
100 IU/mL
|
Solution For Injection (Sc)
|
Long-acting Insulin
|
Wockhardt Ltd.
|
India
|
Renewal
|
16 November 2023
|
03 March 2029
|
| View |
|
BRP-037-03
|
Insulin Glargine
|
Glarsulin
|
100 IU/mL
|
Solution For Injection (Sc)
|
Long-acting Insulin
|
Wockhardt Ltd.
|
India
|
Renewal
|
22 November 2023
|
03 March 2029
|